| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors
|
Thomas, Jacob S.
|
|
|
87 |
4 |
p. 525-532
|
article
|
| 2 |
Concentration–QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia
|
Kang, Dongwoo
|
|
|
87 |
4 |
p. 513-523
|
article
|
| 3 |
Correction to: A placebo‑controlled, double‑blind, randomized study of recombinant thrombomodulin (ART‑123) to prevent oxaliplatin‑induced peripheral neuropathy
|
Kotaka, Masahito
|
|
|
87 |
4 |
p. 585-586
|
article
|
| 4 |
Correlations between serum cetuximab and EGFR-related markers, and skin disorders in head and neck cancer patients
|
Shibata, Kaito
|
|
|
87 |
4 |
p. 555-565
|
article
|
| 5 |
Demethoxycucumin protects MDA-MB-231 cells induced bone destruction through JNK and ERK pathways inhibition
|
Shen, Xiaofeng
|
|
|
87 |
4 |
p. 487-499
|
article
|
| 6 |
Does bevacizumab increase joint pain in patients with cancer? Results of the prospective observational BEVARTHRALGIA study
|
Vauléon, Enora
|
|
|
87 |
4 |
p. 533-541
|
article
|
| 7 |
Dose adjustment of venetoclax when co-administered with posaconazole: clinical drug–drug interaction predictions using a PBPK approach
|
Bhatnagar, Sumit
|
|
|
87 |
4 |
p. 465-474
|
article
|
| 8 |
Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates: a phase I, multicenter, drug–drug interaction study in patients with ALK + advanced tumors
|
Hurtado, Felipe K.
|
|
|
87 |
4 |
p. 475-486
|
article
|
| 9 |
5-Fluorouracil disrupts ovarian preantral follicles in young C57BL6J mice
|
Almeida, Juliana Z.
|
|
|
87 |
4 |
p. 567-578
|
article
|
| 10 |
Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study
|
Feliu, Jaime
|
|
|
87 |
4 |
p. 543-553
|
article
|
| 11 |
Population pharmacokinetic model development and exposure–response analysis of vincristine in patients with malignant lymphoma
|
Igarashi, Toshiaki
|
|
|
87 |
4 |
p. 501-511
|
article
|
| 12 |
Severe toxicity of capecitabine in a patient with DPD deficiency after a safe FEC-100 experience: why we should test DPD deficiency in all patients before high-dose fluoropyrimidines
|
Maillard, Maud
|
|
|
87 |
4 |
p. 579-583
|
article
|
| 13 |
The role of the glutamine transporter ASCT2 in antineoplastic therapy
|
Teixeira, Estefânia
|
|
|
87 |
4 |
p. 447-464
|
article
|
Journal description